Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis

Journal of Bone and Mineral Research

Volumn 17, Issue 3, 2002, Pages 394-405

  Dang, Z C ^a   Van Bezooijen, R L ^a   Karperien, M ^a   Papapoulos, S E ^a   Lowik C W G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adipocyte; Bone marrow; Core binding factor 1; Estrogen receptors; Osteoblast; Peroxisome proliferator activated receptor

Indexed keywords

ADIPOCYTE PROTEIN 2; ALKALINE PHOSPHATASE; CORE BINDING FACTOR; DEXAMETHASONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INSULIN; ISOBUTYLMETHYLXANTHINE; LIPOPROTEIN LIPASE; OSTEOCALCIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CLONE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

EID: 0036182265     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.3.394     Document Type: Article

References (58)

1. Molecular and cellular mechanisms of estrogen action on the skeleton
2. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?
3. Interconversion potential of cloned human marrow adipocytes in vitro
4. Marrow stromal stem cells
5. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: Evidence for autonomy from factors released during bone resorption
6. Hormonal control of regional fat distribution
7. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: Evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor γ2
8. Estrogen suppresses transcription of lipoprotein lipase gene
9. Nuclear estradiol binding in rat adipocytes regional variations and regulatory influences of hormones
10. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue
11. Increased adipose tissue in male and female estrogen receptor-α knockout mice
12. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
13. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women
14. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1
15. Transcriptional regulation of adipogenesis
16. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
17. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival
18. Effect of tamoxifen on serum lipid metabolism
19. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation
20. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton
21. Skeletal effects of estrogens
22. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
23. Estrogen receptor β acts as a dominant regulator of estrogen signaling
24. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regulator of estrogen action
25. A PCR analysis of ERalpha and ERbeta mRNA abundance in rats and the effect of ovariectomy
26. Expression of estrogen receptor beta in rat bone
27. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells
28. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells
29. Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4
30. Genistein and 17β-estradiol stimulate osteoblastogenesis but inhibit adipogenesis
31. A simple, rapid, and sensitive DNA assay procedure
32. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture
33. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
34. IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice
35. Multipotency of a bone marrow stromal cell line, TBR31-2, established from ts-SV40 T antigen gene transgenic mice
36. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro
37. Estrogen receptors α and β: Two receptors of a kind?
38. Anabolic therapy for osteoporosis
39. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture
40. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females
41. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse
42. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells
43. Progesterone and dexamethasone stimulate proliferation and differentiation of osteoprogenitors and progenitors for adipocytes and macrophages in cell populations derived from adult rat vertebrae
44. Progesterone stimulates proliferation and differentiation of osteoprogenitor cells in bone cell populations derived from adult female but not from adult male rats
45. OSF2/Cbfa1: A transcriptional activator of osteoblast differentiation
46. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2
47. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
48. Tamoxifen inhibits lipoprotein activity: In vivo and in vitro studies
49. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis
50. Coactivators and corepressors as mediators of nuclear receptor function: An update
51. Modulation of estrogen receptor-α transcriptional activity by the coactivator PGC-1
52. The effects of the estrogen receptor blocker, Faslodex (ICI182,780), on estrogen-accelerated bone maturation in mice
53. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
54. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
55. Differential expression of estrogen receptor beta splice variants in rat brain: Identification and characterization of a novel variant missing exon 4
56. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha
57. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: Histomorphometric evidence in a longitudinal study
58. Sex steroids and bone